02/14/2019
Bio-Rad’s QXDx AutoDG ddPCR System is now an FDA-cleared diagnostic solution available for monitoring molecular response in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
02/01/2019
Bio-Rad’s ZE5 Cell Analyzer is now automation-ready.
01/20/2019
During a Bio-Rad workshop at PMWC, panelists will discuss how Droplet Digital PCR helps physicians monitor immunotherapy effectiveness in patients.
11/12/2018
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced
that the company has been awarded a contract for iQ-Check real-time PCR pathogen detection test kits and the iQ-Check Prep Automation System from the United States Department of Agriculture’s Food Safety and Inspection Service (USDA FSIS).
10/29/2018
Research from NYU Langone Medical Center and its Perlmutter Cancer Center along with Bio-Rad’s Digital Biology Group demonstrates how two new ddPCR-based assays can specifically detect and quantify mutations linked to many cancer types.
09/19/2018
The scATAC-Seq solution allows researchers to gain a deeper understanding about the mechanisms of cell fate, identify the cell types present in heterogeneous tissues, and validate single-cell gene expression data.
08/30/2018
Bio-Rad Laboratories, Inc. announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.
06/24/2018
In clinical trials, researchers are increasingly turning to Droplet Digital PCR to measure cell-free tumor DNA as a biomarker of treatment response.
06/19/2018
Bio-Rad's RAPID chromogenic media and MALDI Biotyper® from Bruker are used together by labs to detect the presence of pathogens in food and confirm/identify the organism.
05/09/2018
StarBright Blue 520 Fluorescent Secondary Antibodies offer highly sensitive fluorescent detection and multiplexing for detecting up to three unique proteins on a western blot.